Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
This study has been completed.
First Posted: May 11, 2011
Last Update Posted: August 27, 2015
The Leukemia and Lymphoma Society
Information provided by (Responsible Party):
Celgene ( Celgene Corporation )